AKT1 and glioblastoma: It shows a solid antiproliferative activity in a group of GBM cell lineages through reduction of Akt, GSK3β, and p70S6 K phosphorylation, decreased cyclin D expression, and induction of cell cycle arrest in the G1 phase.